Genetic Counselling
Genetic counselling is increasingly important in neurology with growing test availability. The session covers Huntington pre-symptomatic testing protocols (including pre-test counselling, informed consent, post-test support), ALS genetic counselling (SOD1, C9orf72, FUS), familial Alzheimer's testing considerations (APP, PSEN1, PSEN2, APOE), polygenic risk score communication challenges, the ethical considerations of CNS genetic testing in childhood, and the return-of-results frameworks. Discussion addresses direct-to-consumer genetic testing implications, family-cascade testing approaches, the role of genetic counsellors in research, the patient-experience implications, and the equity and access considerations for genetic testing.
- HD pre-symptomatic testing
- ALS genetic counselling
- Familial AD testing
- Polygenic risk communication
- Childhood testing ethics
- Return-of-results frameworks
- Direct-to-consumer testing
- Family cascade testing
Explore the full GCNN 2027 program
- 01Stroke & Cerebrovascular Disease
- 02Alzheimer’s & Dementia
- 03Multiple Sclerosis
- 04Parkinson’s & Movement Disorders
- 05Epilepsy
- 06Neuromuscular Disease
- 07Headache Medicine
- 08Neuro-Oncology
- 09Clinical Neuroscience & AI
- 10Spinal Cord Injury
- 11Traumatic Brain Injury
- 12Sleep Disorders
- 13Neuropathic Pain
- 14Cerebellar & Ataxia Disorders
- 15Functional Neurological Disorders
- 16Pediatric Neurology
- 17Neuroimmunology
- 18Brain-Computer Interfaces
- 19Migraine
- 20Cluster Headache
- 21Dementia with Lewy Bodies
- 22Frontotemporal Dementia
- 23Huntington Disease
- 24ALS
- 25Tremor & Dystonia
- 26Restless Legs Syndrome
- 27Neuroinfectious Disease
- 28Brain Tumors
- 29Vestibular Disorders
- 30Autonomic Disorders
- 31Functional Imaging
- 32Neuro-Ophthalmology
- 33Neuropsychology
- 34Movement Disorder Surgery